Testosterone Treatment And Cardiovascular Events

Testosterone Treatment And Cardiovascular Events

Sermorelin is a biological active analogue of growth hormone releasing hormone (GHRH) that is produced by the human brain to stimulate production and release of growth hormone by the pituitary gland. Prostate cancer and benign prostate enlargement are regarded as stimulated by testosterone. Because treatments for both conditions include androgen suppression, the possibility of increased risk of these afflictions with testosterone supplementation is of great concern. Testosterone treatment has been linked with increased prostate volume, although not always high that was above -ordinary levels.



testosterone therapy side effects acneGirls with diminished sex drive have been shown to have lower free testosterone levels. In a 12-week trial 51 of 34 women, testosterone therapy (1% lotion, 10 milligrams per day applied to the thigh) improved well-being, mood, and sexual function in premenopausal women with low libido and low testosterone levels. Testosterone is used for women with HIV infection, Turner's syndrome, premature ovarian failure, or chronic corticosteroid use.


He also stressed that given these study results, it's important for doctors to continue to vigorously manage recognized cardiovascular disease risk factors in patients, as testosterone therapy may not have an impact. These two studies come on the heels of a recent pooled analysis by researchers at Beth Israel Deaconess Medical Center in Boston, which cast further doubt on the link between testosterone therapy and cardiovascular risk and suggested a positive association between higher testosterone levels and improvements in decrease in cardiovascular risk. It's a medical fact that all men and girls start to age quicker after they reach their forties.

To put it differently, the men who used testosterone therapy had a 30 percent increased risk of heart attack, stroke or dying, compared with men who didn't use the hormone, and the results held after being corrected for several other variables that could have influenced the outcomes, according to the study, published today (Nov. Patients and http://www.rand.org/news/press/2005/05/31.html doctors should be vigilant of the aggressive promotion used by testosterone makers, Cappola said. The researchers said the new study was prompted by a recent clinical trial of testosterone therapy in guys who were at high risk for heart disease.